作者：
Dai,Chihara [1]
;
Raphael E,Steiner [2]
;
Ranjit,Nair [3]
;
Lei,Feng [4]
;
Sairah,Ahmed [5]
;
Paolo,Strati [6]
;
Luis E,Malpica Castillo [7]
;
Donna,Griffith [7]
;
Shivon A,Mathew [1]
;
Wirt,Montinez [1]
;
Gita,Masand [1]
;
Felipe,Samaniego [1]
;
Maria Alma,Rodriguez [8]
;
Fredrick B,Hagemeister [9]
;
Luis E,Fayad [1]
;
Swaminathan P,Iyer [8]
;
Loretta J,Nastoupil [7]
;
Sattva S,Neelapu [7]
;
Christopher R,Flowers [6]
;
Jason R,Westin [10]
作者单位：
University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States.
[1]
Memorial Sloan Kettering Cancer Center, New York, New York, United States.
[2]
MD Anderson Cancer Center:, Houston, Texas, United States.
[3]
MD Anderson, Houston, Texas, United States.
[4]
University of Texas, MD Anderson Cancer Center, Houston, Texas, United States.
[5]
UT MD Anderson Cancer Center, Houston, Texas, United States.
[6]
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
[7]
MD Anderson Cancer Center, Houston, Texas, United States.
[8]
Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, Texas, United States.
[9]
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States.
[10]
DOI
10.1182/bloodadvances.2024014635
PMID
39908461
发布时间
2025-02-05
换一批
换一批
